The Selenium and Vitamin E Cancer Prevention Trial

[1]  J. Crowley,et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.

[2]  B. Turnbull,et al.  Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial , 2003, BJU international.

[3]  R. Hayes,et al.  Serum selenium and risk of prostate cancer in U.S. blacks and whites , 2003, International journal of cancer.

[4]  D. Bostwick,et al.  Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. , 2003, Journal of the National Cancer Institute.

[5]  B. Pittman,et al.  Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  T. Slaga,et al.  Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. , 2002, Molecular cancer therapeutics.

[7]  Y. Seo,et al.  Selenomethionine regulation of p53 by a ref1-dependent redox mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Cheryl Jorcyk,et al.  Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. , 2002, Cancer research.

[9]  L. Klotz,et al.  Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. , 2002, Cancer research.

[10]  H. Ganther,et al.  Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. , 2002, Cancer research.

[11]  E. Metter,et al.  Plasma selenium level before diagnosis and the risk of prostate cancer development. , 2001, The Journal of urology.

[12]  G. Omenn,et al.  Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  A. Sabichi,et al.  Selenium effects on prostate cell growth. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[15]  G. Combs,et al.  Serum selenium and subsequent risk of prostate cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  H. Ganther,et al.  In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. , 2000, Cancer research.

[17]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[18]  R A Stephenson,et al.  Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.

[19]  E. Rimm,et al.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. , 1998, Journal of the National Cancer Institute.

[20]  B. Turnbull,et al.  Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. , 1998, British journal of urology.

[21]  Y. Yano,et al.  The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in mice based on the regulation of polyamine metabolism. , 1998, Cancer letters.

[22]  D. Albanes,et al.  The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  E. Constant,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. , 1998 .

[24]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[25]  L. Clark,et al.  Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. , 1998, Cancer letters.

[26]  H. Yamazaki,et al.  Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. , 1997, Cancer research.

[27]  P. Taylor,et al.  Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. , 1997, American journal of epidemiology.

[28]  E. Feskens,et al.  Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer. The Zutphen Study. , 1997, American journal of epidemiology.

[29]  M. Rayman.  Dietary selenium: time to act. , 1997, BMJ.

[30]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[31]  M. Eichholzer,et al.  Prediction of male cancer mortality by plasma levels of interacting vitamins: 17‐year follow‐up of the prospective Basel study , 1996, International journal of cancer.

[32]  A. Azzi,et al.  Vitamin E: a sensor and an information transducer of the cell oxidation state. , 1995, The American journal of clinical nutrition.

[33]  L. Packer,et al.  Vitamin E: beyond antioxidant function. , 1995, The American journal of clinical nutrition.

[34]  W. Wang,et al.  Induction of NAD(P)H:quinone reductase by vitamins A, E and C in Colo205 colon cancer cells. , 1995, Cancer letters.

[35]  C. la Vecchia,et al.  Selected micronutrient intake and the risk of colorectal cancer. , 1994, British Journal of Cancer.

[36]  Cheng Jiang,et al.  Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. , 1994, Carcinogenesis.

[37]  T. Sellers,et al.  Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. , 1993, Cancer research.

[38]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[39]  P. Taylor,et al.  Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. , 1993, Journal of the National Cancer Institute.

[40]  E. White,et al.  Alcohol and nutrients in relation to colon cancer in middle-aged adults. , 1993, American journal of epidemiology.

[41]  N. Nair,et al.  Selenium--its biological perspectives. , 1993, Medical hypotheses.

[42]  L. Packer,et al.  Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. , 1993, Biochimica et biophysica acta.

[43]  B. Henderson,et al.  Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. , 1992, British Journal of Cancer.

[44]  M. Longnecker,et al.  Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. , 1992, Journal of the National Cancer Institute.

[45]  G W Comstock,et al.  Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. , 1992, American journal of epidemiology.

[46]  A. Rissanen,et al.  Dietary antioxidants and the risk of lung cancer. , 1991, American journal of epidemiology.

[47]  M. Hirose,et al.  Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis. , 1991, Cancer letters.

[48]  B. Polk,et al.  Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. , 1990, Journal of the National Cancer Institute.

[49]  J. Freudenheim,et al.  Risks associated with source of fiber and fiber components in cancer of the colon and rectum. , 1990, Cancer research.

[50]  R. Peto,et al.  Serum selenium and subsequent risk of cancer among Finnish men and women. , 1990, Journal of the National Cancer Institute.

[51]  N. Day,et al.  Colorectal cancer and diet in an asian population—A case‐control study among Singapore Chinese , 1989, International journal of cancer.

[52]  W. Willett,et al.  Selenium and cancer. , 1988, Nutrition reviews.

[53]  R. Coates,et al.  Serum levels of selenium and retinol and the subsequent risk of cancer. , 1988, American journal of epidemiology.

[54]  A. Azzi,et al.  Vitamin E inhibits protein kinase C activity. , 1988, Biochemical and biophysical research communications.

[55]  B. Henderson,et al.  A Prospective Study” , 2007 .

[56]  G. Stotzky,et al.  Selenium and immune responses. , 1987, Environmental research.

[57]  M. Webber,et al.  Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro. , 1985, Biochemical and biophysical research communications.

[58]  W. Willett,et al.  PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCER , 1983, The Lancet.

[59]  F. Umeda,et al.  Effect of vitamin E on function of pituitary-gonadal axis in male rats and human subjects. , 1982, Endocrinologia japonica.

[60]  K. Ingold,et al.  Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro , 1981 .

[61]  J. Wedderburn.  Selenium and cancer. , 1972, New Zealand veterinary journal.

[62]  R. Shamberger,et al.  Possible protective effect of selenium against human cancer. , 1969, Canadian Medical Association journal.

[63]  R. Weale,et al.  FIVE YEARS' GRACE. , 1964, Lancet.

[64]  H. Evans,et al.  ON THE EXISTENCE OF A HITHERTO UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION. , 1922, Science.

[65]  H. Ganther,et al.  New Concepts in Selenium Chemoprevention , 2004, Cancer and Metastasis Reviews.

[66]  L. Hawthorn,et al.  Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. , 2003, Cancer research.

[67]  A. LaCroix,et al.  A case-control study of toenail selenium and cancer of the breast, colon, and prostate. , 2000, Cancer detection and prevention.

[68]  A. Papas.  Antioxidant Status, Diet, Nutrition, and Health , 1998 .

[69]  A. Anagnostou,et al.  dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. , 1997, Nutrition and cancer.

[70]  P. Ottino,et al.  Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. , 1997, Free radical biology & medicine.

[71]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.

[72]  B. G. Sanders,et al.  RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. , 1995, Nutrition and cancer.

[73]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[74]  A. Diplock,et al.  Antioxidants and disease prevention. , 1994, Molecular aspects of medicine.

[75]  G. Birch.  Handbook of vitamins 2nd edition , 1992 .

[76]  K. Helzlsouer,et al.  Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. , 1991, The American journal of clinical nutrition.

[77]  L. Machlin.  Handbook of Vitamins , 1991 .

[78]  R. Peto,et al.  Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. , 1988, American journal of epidemiology.

[79]  D. Medina,et al.  Current Concepts of Selenium and Mammary Tumorigenesis , 1987 .

[80]  D. Medina,et al.  Cellular and Molecular Biology of Mammary Cancer , 1987, Springer US.

[81]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.